Sort   by:  
 Page size 
UnknownCardiac fibroblast-specific p38α MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism.
Not available
S-EPMC6629170 | biostudies-literature
UnknownSickle Cell Disease Subjects Have a Distinct Abnormal Autonomic Phenotype Characterized by Peripheral Vasoconstriction With Blunted Cardiac Response to Head-Up Tilt.
Not available
S-EPMC6470196 | biostudies-literature
UnknownSerum Type I Interferon Score for Prediction of Clinically Meaningful Disease Progression in Limited Cutaneous Systemic Sclerosis.
Not available
S-EPMC12209744 | biostudies-literature
UnknownA randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis.
Not available
S-EPMC7677494 | biostudies-literature
UnknownMolecular Basis for Dysregulated Activation of NKX2-5 in the Vascular Remodeling of Systemic Sclerosis.
Not available
S-EPMC6001790 | biostudies-literature
UnknownOptical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis.
Not available
S-EPMC5324107 | biostudies-literature
UnknownEarly treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study).
Not available
S-EPMC6815440 | biostudies-literature
UnknownDyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial.
Not available
S-EPMC9629379 | biostudies-literature
UnknownMulti-omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosis.
Not available
S-EPMC12631162 | biostudies-literature
UnknownChilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy.
Not available
S-EPMC8221732 | biostudies-literature
Sort   by:  
 Page size